BiotechTube
Home/TRIMT/Dr. Falco Reissig
DF

Dr. Falco Reissig

Principal Scientist

TRIMT

Therapeutic Areas

Oncology

TRIMT Pipeline

DrugIndicationPhase
Trivehexinαvβ6 Integrin-positive CancersPreclinical
Therahexinαvβ6 Integrin-positive CancersPreclinical
Technehexinαvβ6 Integrin-positive CancersPreclinical
Triveoctinαvβ8 Integrin-positive CancersPreclinical
LPDL1PD-L1 positive CancersPreclinical
Undisclosed αvβ6 Integrin Dxαvβ6 Integrin-positive CancersDiscovery

Leadership Team at TRIMT

DD
Dr. Dirk Freitag-Stechl, MBA
Managing Partner
PD
PD Dr. Johannes Notni
Managing Partner, Chief Science Officer
DM
Dr. Matthias Keck
Head of Operations (Sales, Quality, Projects)
View full TRIMT profile